Accelerating Digital Health Innovation
Startupbootcamp Digital Health Berlin is now entering its 3rd cycle, and is one of the most serious health accelerators in the continent. How, you ask?
Startupbootcamp Digital Health Berlin is now entering its 3rd cycle, and is one of the most serious health accelerators in the continent. How, you ask?
Regulation of adipose tissue metabolism as a potential treatment for heart failure
TissUse continues their successful collaboration with AstraZeneca to establish relevant Microphysiological System (MPS) models based on TissUse’s Multi-Organ-Chip technology.
Attention young scientists!
Are you able to present your life science discovery in 3 minutes in a layman´s language?
Then apply until April 25, win a pitch coaching and save your prize money at our Speed Lecture Award final @ BIONNALE on June 20 in…
Aesculap AG, a subsidiary of B. Braun Melsungen AG, together with Christoph Miethke announced the formation of the joint venture B. Braun Miethke GmbH & Co. KG.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, announced today the acquisition of Metanomics Health GmbH. Metanomics Health is a metabolomics biomarker development and healthcare services specialist based in Berlin, Germany. At…
1. Scope
Germany and Sweden are announcing a Call for Proposals for joint R&D projects, focusing on developing innovative products and applications in all technological and application areas. Applicants are expected to develop products,…
The HIPGEN project at the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) of the Charité – Universitätsmedizin Berlin is committed to improving the mobilization of patients after a hip prosthesis implantation after femoral neck fracture.…
Charité-based neuroscientists launch an initiative aimed at fostering scientific collaboration and exchange
HV Holtzbrinck Ventures invests 3 million euros in the German startup heartbeat medical, a cutting-edge software company that is revolutionizing the way doctors and hospitals evaluate the success of their treatments. Existing investor, the High-Tech…